Specialty Pharmacy

Top news of the day from across the healthcare landscape.

Vestronidase alfa-vjbk (Mepsevii) approved to treat mucopolysaccharidosis.

The efficacy and safety of an adalimumab biosimilar matched the reference products in switching studies treating plaque psoriasis and rheumatoid arthritis.

Exposure to ammonia found to amplify breast cancer cell proliferation.

Marc O’Connor, chief operating officer, Curant Health, discusses the best ways for pharmacies to succeed in the shift to value-based care.

Significant gains have been made against viral hepatitis.

Top news of the day from across the healthcare landscape.

There is a growing need to develop standards for measuring outcomes among patients treated with specialty drugs.

Identification of the last unknown protein in HIV could lead to a cure for the virus.

Top news of the day from across the healthcare landscape.

Aripiprazole tablets with sensor (Abilify MyCite) transmits information to an app when ingested.

Nine other countries are on track to eliminate the hepatitis C virus by 2030.

Nearly all patients treated with dasatinib (Sprycel) achieved a complete cyotgenic response.

Elvin Montanez, PharmD, chief operations officer at BioPlus Specialty Pharmacy, discusses what pharmacy benefit managers look for in a specialty pharmacy.

Amazon’s fulfillment center in Indiana is located adjacent to an Express Scripts location: is this coincidence or a sign of the future?

The Mediterranean diet has been found to provide significant health benefits.

New study may result in targeted colon cancer prevention measures.

Top news of the day from across the healthcare landscape.

Gut microbiome alterations have been associated with frailty in older individuals with HIV.

John Giannouris, vice president, Specialty Pharmacy Services, ValueCentric, discusses how data connectivity is crucial for the specialty pharmacy industry.

Lack of federal oversight for cannabidiol products sold online could lead to adverse events among patients who take the products for conditions such as cancer.

Specialty pharmacists play a critical role in patient care.

Top news of the day from across the healthcare landscape.

Top news of the week from Specialty Pharmacy Times.

Study finds association between warfarin use and cancer incidence to determine whether warfarin has anticancer potential.

Heplisav-B is the only 2-dose hepatitis B vaccine recombinant approved in the United States.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

Brentuximab vedotin (Adcetris) improves survival among patients with anaplastic large cell lymphoma or CD30-expressing mycosis fungoides.